Your browser doesn't support javascript.
loading
Taurine and coenzyme Q10 synergistically prevent and reverse chlorpromazine-induced psycho-neuroendocrine changes and cataleptic behavior in rats.
Oyovwi, Mega O; Nwangwa, Eze K; Ben-Azu, Benneth; Edesiri, Tesi P; Emojevwe, Victor; Igweh, John C.
Afiliación
  • Oyovwi MO; Department of Human Physiology, Faculty of Basic Medical Sciences, Delta State University, Abraka, Delta State, Nigeria.
  • Nwangwa EK; Department of Basic Medical Science, Achievers University, Owo, Ondo State, Nigeria.
  • Ben-Azu B; Department of Human Physiology, Faculty of Basic Medical Sciences, Delta State University, Abraka, Delta State, Nigeria.
  • Edesiri TP; Department of Pharmacology, Faculty of Basic Medical Science, PAMO University of Medical Sciences, Port Harcourt, Rivers State, Nigeria. pharmben4ever@yahoo.com.
  • Emojevwe V; Department of Science Laboratory Technology, Delta State Polytechnic, Ogwashi-Uku, Delta State, Nigeria.
  • Igweh JC; Department of Physiology, Faculty of Baic Medical Sciences, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Naunyn Schmiedebergs Arch Pharmacol ; 394(4): 717-734, 2021 04.
Article en En | MEDLINE | ID: mdl-33146779
Over the years, mounting evidences have suggested a strong association between chronic chlorpromazine therapy, a popular first-generation antipsychotic drug, and psycho-neuroendocrine changes. In this study, we aim to examine whether treatment with taurine and coenzyme Q10 (COQ-10), compounds with steroidogenic-gonadotropin hormone-enhancing properties, can attenuate the negative impacts of chlorpromazine on steroidogenic, gonadotropin, thyroid and HPA-axis hormones, dopamine levels, catalepsy behavior and neuronal cells of the hypothalamus and pituitary gland in the preventive and reversal treatments in male Wister rats. In the drug treatment alone or preventive protocol, rats received oral administration of saline (10 mL/kg), taurine (150 mg/kg/day), COQ-10 (10 mg/kg/day), or both (taurine + COQ-10/day) alone for 56 consecutive days, or in combination with oral chlorpromazine (30 mg/kg/day) treatment from days 29 to 56. In the reversal protocol, the animals received chlorpromazine or saline for 56 days prior to taurine, COQ-10, or the combination from days 29 to 56. Thereafter, serum prolactin, steroidogenic (testosterone, estrogen, progesterone), gonadotropin (luteinizing hormone, LH, follicle-stimulating hormone, FSH), thyroid (thyrotropin-stimulating hormone, tetraiodothyronine, triiodothyronine) hormones, corticosterone, brain dopamine levels and cataleptic behavior were investigated. The histopathological features of the hypothalamus and pituitary gland were also evaluated. Taurine, COQ-10, or their combination prevented and reversed chlorpromazine-induced hyperprolactinemia, decrease in FSH, LH, testosterone, progesterone and dopamine concentrations, as well as the increase in estrogen levels. Taurine and COQ-10 reduced the changes in thyroid hormones, corticosterone release, histological distortions of the hypothalamus and the pituitary gland of chlorpromazine-treated rats. Taurine and COQ-10 attenuated chlorpromazine-induced catalepsy. The study showed that taurine and COQ-10 prevented and reversed chlorpromazine-induced changes in reproductive, thyroid hormones, dopamine level, corticosterone release, neurodegenerations, and cataleptic behavior in rats.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taurina / Antipsicóticos / Catalepsia / Clorpromazina / Ubiquinona / Fármacos Neuroprotectores Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Nigeria Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taurina / Antipsicóticos / Catalepsia / Clorpromazina / Ubiquinona / Fármacos Neuroprotectores Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Nigeria Pais de publicación: Alemania